Endotypes of severe allergic asthma patients who clinically benefit from Anti-IgE therapy

C. Huang (Taipei, Taiwan), Y. Huang (Taipei, Taiwan), C. Weng (Taipei, Taiwan), M. Lee (Taipei, Taiwan), C. Wang (Taipei, Taiwan), H. Kuo (Taipei, Taiwan)

Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Session: Studying novel biomarkers in asthma and COPD
Session type: Thematic Poster
Number: 957
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Huang (Taipei, Taiwan), Y. Huang (Taipei, Taiwan), C. Weng (Taipei, Taiwan), M. Lee (Taipei, Taiwan), C. Wang (Taipei, Taiwan), H. Kuo (Taipei, Taiwan). Endotypes of severe allergic asthma patients who clinically benefit from Anti-IgE therapy. 957

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: